Ardent Health Partners, LLC carries a market capitalization of 1.12B, placing it among publicly traded companies globally. Its enterprise value stands at 3.28B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.12B |
| Enterprise Value | 3.28B |
Ardent Health Partners, LLC currently has 143.13M shares outstanding.
| Shares Outstanding | 143.13M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Ardent Health Partners, LLC trades at a trailing price-to-earnings ratio of 8.99. The price-to-sales ratio is 0.19, and the price-to-book ratio stands at 2.23.
| PE Ratio | 8.99 |
| PS Ratio | 0.19 |
| PB Ratio | 2.23 |
| P/TBV Ratio | 1.58 |
| P/FCF Ratio | 1.86 |
| P/OCF Ratio | 2.77 |
On an enterprise value basis, Ardent Health Partners, LLC trades at an EV/EBITDA multiple of 6.53 and an EV/FCF ratio of 4.72. The EV/Sales ratio of 0.51 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 9.66 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.51 |
| EV / EBITDA | 6.53 |
| EV / EBIT | 9.66 |
| EV / FCF | 4.72 |
Ardent Health Partners, LLC maintains a current ratio of 2.12, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 132.03, indicating elevated leverage, while an interest coverage ratio of 9.43 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 2.12 |
| Quick Ratio | 1.36 |
| Debt / Equity | 132.03 |
| Debt / EBITDA | 4.55 |
| Interest Coverage | 9.43 |
Ardent Health Partners, LLC posts a return on equity of 28.27 and a return on invested capital of 6.92.
| Return on Equity (ROE) | 28.27 |
| Return on Assets (ROA) | 2.64 |
| Return on Invested Capital (ROIC) | 6.92 |
| Return on Capital Employed (ROCE) | 2.59 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 31.26 |
Over the trailing twelve months, Ardent Health Partners, LLC has paid 57.09M in income taxes, reflecting an effective tax rate of 19.91.
| Income Tax | 57.09M |
| Effective Tax Rate | 19.91 |
Ardent Health Partners, LLC's stock has declined approximately -46.25944% over the past 52 weeks. The 50-day moving average sits at 9.46, while the 200-day moving average is 10.58.
| Beta (5Y) | N/A |
| 52-Week Price Change | -46.25944% |
| 50-Day Moving Average | 9.46 |
| 200-Day Moving Average | 10.58 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Ardent Health Partners, LLC generated 6.43B in revenue and converted that into 134.28M in net income, yielding earnings per share of 1.62. EBITDA reached 501.89M, while operating income came in at 339.41M.
| Revenue | 6.43B |
| Gross Profit | 2.67B |
| Operating Income | 339.41M |
| Pretax Income | 286.75M |
| Net Income | 134.28M |
| EBITDA | 501.89M |
| EBIT | 339.41M |
| Earnings Per Share (EPS) | 1.62 |
Ardent Health Partners, LLC holds 609.69M in cash and equivalents against 2.29B in total debt, resulting in a net debt position of 500.71M. Total book value stands at 541.46M, with working capital of 1.07B providing operational flexibility.
| Cash & Cash Equivalents | 609.69M |
| Total Debt | 2.29B |
| Net Debt | 500.71M |
| Equity (Book Value) | 541.46M |
| Book Value Per Share | 3.84 |
| Working Capital | 1.07B |
Ardent Health Partners, LLC produced 435.08M in operating cash flow over the past twelve months. After subtracting -217.08M in capital expenditures, free cash flow totaled 217.99M - equivalent to 1.55 per share.
| Operating Cash Flow | 435.08M |
| Capital Expenditures | -217.08M |
| Free Cash Flow | 217.99M |
| FCF Per Share | 1.55 |
Ardent Health Partners, LLC operates with a gross margin of 41.61, reflecting its pricing power and cost economics. The operating margin of 5.28 and net profit margin of 2.09 provide insight into operational efficiency.
| Gross Margin | 41.61 |
| Operating Margin | 5.28 |
| Pretax Margin | 4.46 |
| Profit Margin | 2.09 |
| EBITDA Margin | 7.81 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 8.41 |
| FCF Yield | 53.84 |
Ardent Health Partners, LLC posts an Altman Z-Score of 2.44, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.44 |